Rahmer Peter 4
4 · Relay Therapeutics, Inc. · Filed Jan 30, 2025
Insider Transaction Report
Form 4
Rahmer Peter
See remarks
Transactions
- Sale
Common Stock
2025-01-28$4.63/sh−1,673$7,746→ 307,081 total - Award
Common Stock
2025-01-28+139,141→ 446,222 total - Sale
Common Stock
2025-01-29$4.55/sh−26,541$120,762→ 419,681 total - Sale
Common Stock
2025-01-30$4.42/sh−17,250$76,245→ 402,431 total
Footnotes (8)
- [F1]Sale of shares to cover the reporting person's income tax withholding obligations upon the vesting of 5,505 shares of restricted stock units ("RSUs") on January 27, 2025. The reporting person had no discretion with respect to such sale, which was transacted in accordance with the Issuer's policies regarding the vesting of RSUs.
- [F2]Includes 284,033 shares underlying RSUs.
- [F3]Represents RSUs granted to the reporting person pursuant to the Issuer's 2020 Stock Option and Incentive Plan. Each RSU represents a contingent right to receive one share of the Issuer's common stock upon vesting.
- [F4]Includes 423,174 shares underlying RSUs.
- [F5]Sale of shares to cover the reporting person's income tax withholding obligations upon the vesting of 100,000 shares of RSUs on January 28, 2025. The reporting person had no discretion with respect to such sale, which was transacted in accordance with the Issuer's policies regarding the vesting of RSUs.
- [F6]Includes 323,174 shares underlying RSUs.
- [F7]Sale of shares to cover the reporting person's income tax withholding obligations upon the vesting of 69,570 shares of RSUs on January 29, 2025. The reporting person had no discretion with respect to such sale, which was transacted in accordance with the Issuer's policies regarding the vesting of RSUs.
- [F8]Includes 253,604 shares underlying RSUs.